Blog

News February 23, 2021

AbSci Announces Strategic Investment

– AbSci announced a strategic equity investment by Merck Global Health Innovation Fund. – Merck GHI is a fund of Merck Research Laboratories. – AbSci is a leading synthetic biology company that translates ideas into drugs with a revolutionary platform technology that reinvents the biopharmaceutical drug discovery process.